Tidal Investments’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-35,943
Closed -$293K 2758
2026
Q1
$293K Buy
+35,943
New +$326K ﹤0.01% 2053
2024
Q4
Sell
-500,000
Closed -$6.32M 1947
2024
Q3
$6.32M Sell
500,000
-133,411
-21% -$1.72M 0.07% 278
2024
Q2
$8.02M Buy
633,411
+597,395
+1,659% +$6.01M 0.11% 173
2024
Q1
$172K Buy
+36,016
New +$167K ﹤0.01% 1574
2022
Q2
Sell
-3,297
Closed -$243K 1161
2022
Q1
$243K Buy
3,297
+437
+15% +$39K 0.01% 926
2021
Q4
$409K Buy
2,860
+434
+18% +$74.6K 0.01% 677
2021
Q3
$503K Buy
2,426
+404
+20% +$89K 0.02% 515
2021
Q2
$429K Buy
+2,022
New +$370K 0.02% 472
2019
Q2
Sell
-2,254
Closed -$24K 131
2019
Q1
$24K Hold
2,254
0.02% 106
2018
Q4
$82K Buy
+2,254
New +$87.4K 0.06% 89

Other funds holding NVAX

Tidal Investments's NVAX Position: Q2 2026 in Review

Tidal Investments sold out of Novavax (NVAX) in Q2 2026, closing a stake of 35,943 shares — an estimated $293K sold.

Tidal Investments first reported a position in NVAX in Q4 2018 and held it in 10 quarters. The position peaked at $8.02M in Q2 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Tidal Investments reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Tidal Investments sold 35,943 Novavax shares in Q2 2026, an estimated $293K.
  • Tidal Investments first reported a position in Novavax in Q4 2018 and held it in 10 quarters.
  • Tidal Investments's Novavax position peaked at $8.02M in Q2 2024.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.